Description
A prodrug form of diclofenac; decreases paw thickness in a rat model of carrageenan-induced paw edema at 100 μmol/kg; decreases acetic acid-induced writhing in mice at 100 μmol/kg; has reduced ulcerogenicity in rats compared to diclofenac; a degradation product of diclofenac resulting from photo-transformation or spontaneous cyclization in strongly acidic pH conditions; has been used as a synthetic intermediate in the synthesis of compounds with anticancer activity as well as compounds with COX-1, COX-2, and/or 5-LO inhibitory activity
Formal name: 1-(2,6-dichlorophenyl)-1,3-dihydro-2H-indol-2-one
Synonyms: 1-(2,6-Dichlorophenyl)oxindole|Diclofenac Lactam|NSC 621845
Molecular weight: 278.1
CAS: 15362-40-0
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Cyclooxygenases||Research Area|Immunology & Inflammation|Arthritis (Non-autoimmune)||Research Area|Immunology & Inflammation|Autoimmunity|Rheumatoid Arthritis||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Prostaglandins||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway||Research Area|Neuroscience|Pain Research